Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Akums Drugs and Pharmaceuticals Limited has submitted a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate was issued by the company's Registrar & Share Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime). It confirms that all share dematerialisation requests received from depository participants during the quarter ended 31st December 2025 were processed, verified, and confirmed to the depositories within the prescribed timelines. Physical share certificates received for demat were mutilated and cancelled, and the depository's name has been substituted as the registered owner in the company's register of members. The filing was signed by the Company Secretary, Dharamvir Malik, on 7th January 2026.
This is a routine quarterly compliance filing with no material impact on the company's operations, financials, or share price. It simply confirms that shareholder demat requests were handled properly during the October-December 2025 quarter.